Menu
Back to Journals » Cancer Management and Research » Volume 4 » default
Cancer Management and Research
ISSN: 1179-1322
- View all (4488)
- Volume 15, 2023 (47)
- Volume 14, 2022 (330)
- Volume 13, 2021 (890)
- Volume 12, 2020 (1256)
- Volume 11, 2019 (969)
- Volume 10, 2018 (645)
- Volume 9, 2017 (89)
- Volume 8, 2016 (17)
- Volume 7, 2015 (33)
- Volume 6, 2014 (43)
- Volume 5, 2013 (41)
- Volume 4, 2012 (47)
- Volume 3, 2011 (32)
- Volume 2, 2010 (32)
- Volume 1, 2009 (17)
Archive: Volume 4, 2012
The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms
Luong KV, Nguyen LT
Cancer Management and Research 2012, 4:431-445
Published Date: 18 December 2012
Clinical factors related to long-term administration of sorafenib in patients with hepatocellular carcinoma
Nojiri S, Kusakabe A, Fujiwara K, Shinkai N, Matsuura K, Iio E, Miyaki T, Nomura T, Sobue S, Sano H, Hasegawa I, Ohno T, Takahashi Y, Orito E, Joh T
Cancer Management and Research 2012, 4:423-429
Published Date: 18 December 2012
Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy
Chan DL, Morris DL, Rao A, Chua TC
Cancer Management and Research 2012, 4:413-422
Published Date: 23 November 2012
New drugs and combinations for the treatment of soft-tissue sarcoma: a review
Somaiah N, von Mehren M
Cancer Management and Research 2012, 4:397-411
Published Date: 23 November 2012
Carmustine enhances the anticancer activity of selenite in androgen-independent prostate cancer cells
Thamilselvan V, Menon M, Thamilselvan S
Cancer Management and Research 2012, 4:383-395
Published Date: 9 November 2012
Breast imaging reports for malignant lesions: are we maintaining recommended BI-RADS® lexicon standards?
Masroor I, Azeemuddin M, Sakhawat S, Beg M, Sohail S, Ahmed R, Ul-Haq I, Mehboob J
Cancer Management and Research 2012, 4:379-382
Published Date: 7 November 2012
Current treatment options for the management of esophageal cancer
Mawhinney MR, Glasgow RE
Cancer Management and Research 2012, 4:367-377
Published Date: 2 November 2012
Autophagy as a target for cancer therapy: new developments
Carew JS, Kelly KR, Nawrocki ST
Cancer Management and Research 2012, 4:357-365
Published Date: 11 October 2012
Pelvic exenteration for colorectal cancer: oncologic outcome in 59 patients at a single institution
López-Basave HN, Morales-Vásquez F, Herrera-Gómez Á, Padilla Rosciano A, Meneses-Garcíá A, Ruiz-Molina JM
Cancer Management and Research 2012, 4:351-356
Published Date: 11 October 2012
The effect of CyberKnife therapy on pulmonary function tests used for treating non-small cell lung cancer: a retrospective, observational cohort pilot study
Agarwal R, Saluja P, Pham A, Ledbetter K, Bains S, Varghese S, Clements J, Kim YH
Cancer Management and Research 2012, 4:347-350
Published Date: 10 October 2012
Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma
Osorio M, Gracia E, Reigosa E, Hernandez J, de la Torre A, Saurez G, Perez K, Viada C, Cepeda M, Carr A, Ávila Y, Rodríguez M, Fernandez LE
Cancer Management and Research 2012, 4:341-345
Published Date: 5 October 2012
Patient perception of disease control and psychological distress
Mazzotti E, Sebastiani C, Marchetti P
Cancer Management and Research 2012, 4:335-340
Published Date: 27 September 2012
Monocyte galactose/N-acetylgalactosamine-specific C-type lectin receptor stimulant immunotherapy of an experimental glioma. Part II: combination with external radiation improves survival
Kushchayev SV, Sankar T, Eggink LL, Kushchayeva YS, Wiener PC, Hoober JK, Eschbacher J, Liu R, Shi FD, Abdelwahab MG, Scheck AC, Preul MC
Cancer Management and Research 2012, 4:325-334
Published Date: 17 September 2012
Monocyte galactose/N-acetylgalactosamine-specific C-type lectin receptor stimulant immunotherapy of an experimental glioma. Part 1: stimulatory effects on blood monocytes and monocyte-derived cells of the brain
Kushchayev SV, Sankar T, Eggink LL, Kushchayeva YS, Wiener PC, Hoober JK, Eschbacher J, Liu R, Shi FD, Abdelwahab MG, Scheck AC, Preul MC
Cancer Management and Research 2012, 4:309-323
Published Date: 17 September 2012
Characteristics and management of immune-related adverse effects associated with ipilimumab, a new immunotherapy for metastatic melanoma
Andrews S, Holden R
Cancer Management and Research 2012, 4:299-307
Published Date: 12 September 2012
Importance of antiresorptive therapies for patients with bone metastases from solid tumors
Talreja DB
Cancer Management and Research 2012, 4:287-297
Published Date: 11 September 2012
Enteric-coated, highly standardized cranberry extract reduces risk of UTIs and urinary symptoms during radiotherapy for prostate carcinoma
Bonetta A, Di Pierro F
Cancer Management and Research 2012, 4:281-286
Published Date: 24 August 2012
Effects of Acanthus ebracteatus Vahl on tumor angiogenesis and on tumor growth in nude mice implanted with cervical cancer
Mahasiripanth T, Hokputsa S, Niruthisard S, Bhattarakosol P, Patumraj S
Cancer Management and Research 2012, 4:269-279
Published Date: 23 August 2012
Lenalidomide for the treatment of relapsed and refractory multiple myeloma
van de Donk NW, Görgün G, Groen RW, Jakubikova J, Mitsiades CS, Hideshima T, Laubach J, Nijhof IS, Raymakers RA, Lokhorst HM, Richardson PG, Anderson KC
Cancer Management and Research 2012, 4:253-268
Published Date: 14 August 2012
Vemurafenib: a new treatment for BRAF-V600 mutated advanced melanoma
Fisher R, Larkin J
Cancer Management and Research 2012, 4:243-252
Published Date: 8 August 2012
Retinoids in the treatment of glioma: a new perspective
Mawson AR
Cancer Management and Research 2012, 4:233-241
Published Date: 7 August 2012
Occupational exposure to wood dust and formaldehyde and risk of nasal, nasopharyngeal, and lung cancer among Finnish men
Siew SS, Kauppinen T, Kyyrönen P, Heikkila P, Pukkala E
Cancer Management and Research 2012, 4:223-232
Published Date: 7 August 2012
The 20th anniversary of interleukin-2 therapy: bimodal role explaining longstanding random induction of complete clinical responses
Coventry BJ, Ashdown ML
Cancer Management and Research 2012, 4:215-221
Published Date: 2 August 2012
Everolimus and mTOR inhibition in pancreatic neuroendocrine tumors
Yim K-L
Cancer Management and Research 2012, 4:207-214
Published Date: 31 July 2012
The bradykinin B2 receptor induces multiple cellular responses leading to the proliferation of human renal carcinoma cell lines
Kramarenko II, Morinelli TA, Bunni MA, Raymond JR Sr, Garnovskaya MN
Cancer Management and Research 2012, 4:195-205
Published Date: 26 July 2012
The tumor microenvironment in prostate cancer: elucidating molecular pathways for therapy development
Corn PG
Cancer Management and Research 2012, 4:183-193
Published Date: 25 July 2012
Update on the management of invasive bladder cancer 2012
Goethuys H, Van Poppel H
Cancer Management and Research 2012, 4:177-182
Published Date: 18 July 2012
Use of transdermal and intravenous granisetron and the ability of the Hesketh score to assess nausea and vomiting induced by multiday chemotherapy
Boccia RV, Clark G, Howell JD
Cancer Management and Research 2012, 4:171-176
Published Date: 3 July 2012
Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution
Tuca A, Guell E, Martinez-Losada E, Codorniu N
Cancer Management and Research 2012, 4:159-169
Published Date: 13 June 2012
Nodal involvement pattern in resectable lung cancer according to tumor location
Saeteng S, Tantraworasin A, Euathrongchit J, Lertprasertsuke N, Wannasopha Y
Cancer Management and Research 2012, 4:151-158
Published Date: 7 June 2012
Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation
Coventry BJ, Ashdown ML
Cancer Management and Research 2012, 4:137-149
Published Date: 28 May 2012
Integrative systems of genomic risk markers for cancer and other diseases: future of predictive medicine
Yuzhalin AE, Kutikhin AG
Cancer Management and Research 2012, 4:131-135
Published Date: 23 May 2012
Emerging new therapeutic applications of capecitabine as a first-line chemotherapeutic agent in the management of advanced carcinomas other than colorectal carcinoma
Kapoor S
Cancer Management and Research 2012, 4:129-130
Published Date: 8 May 2012
Axillary dissection in primary breast cancer: variations of the surgical technique and influence on morbidity
Wojcinski S, Nuengsri S, Hillemanns P, Schmidt W, Deryal M, Ertan K, Degenhardt F
Cancer Management and Research 2012, 4:121-127
Published Date: 27 April 2012
Local tumor progression following lipiodol-based targeted chemoembolization of hepatocellular carcinoma: a retrospective comparison of miriplatin and epirubicin
Iwazawa J, Ohue S, Hashimoto N, Mitani T
Cancer Management and Research 2012, 4:113-119
Published Date: 19 April 2012
Managing arthralgia in a postmenopausal woman taking an aromatase inhibitor for hormone-sensitive early breast cancer: a case study
Bryce J, Bauer M, Hadji P
Cancer Management and Research 2012, 4:105-111
Published Date: 29 March 2012
Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer
Aitini E, Rossi A, Morselli P, Vivorio B, Bruschi A, Bottura C, Colombo GL.
Cancer Management and Research 2012, 4:99-103
Published Date: 27 March 2012
Bevacizumab for the treatment of nonsquamous non-small-cell lung cancer in Portugal: a retrospective, multicenter study
Estevinho F, Soares M, Azevedo I, Queiroga H, Parente B, Brito U, Teixeira E, Sotto-Mayor R, Araújo A
Cancer Management and Research 2012, 4:91-97
Published Date: 13 March 2012
Management of cutaneous T cell lymphoma: new and emerging targets and treatment options
Li JY, Horwitz S, Moskowitz A, Myskowski PL, Pulitzer M, Querfeld C
Cancer Management and Research 2012, 4:75-89
Published Date: 12 March 2012
Reappraisal of the role of dolasetron in prevention and treatment of nausea and vomiting associated with surgery or chemotherapy
Roberts SM, Bezinover DS, Janicki PK
Cancer Management and Research 2012, 4:67-73
Published Date: 24 February 2012
Psychological and sexual disorders in long-term breast cancer survivors
Pumo V , Milone G, Iacono M, Rametta Giuliano S, Di Mari A, Lopiano C, Bordonaro S, Tralongo P
Cancer Management and Research 2012, 4:61-65
Published Date: 24 February 2012
Time associated with intravenous zoledronic acid administration in patients with breast or prostate cancer and bone metastasis
Richhariya A, Qian Y, Zhao Y, Chung K
Cancer Management and Research 2012, 4:55-60
Published Date: 22 February 2012
C-type lectin receptors and RIG-I-like receptors: new points on the oncogenomics map
Kutikhin AG, Yuzhalin AE
Cancer Management and Research 2012, 4:39-53
Published Date: 24 February 2012
Inherited variation in pattern recognition receptors and cancer: dangerous liaisons?
Kutikhin AG, Yuzhalin AE
Cancer Management and Research 2012, 4:31-38
Published Date: 16 February 2012
Are Toll-like receptor gene polymorphisms associated with prostate cancer?
Kutikhin AG, Yuzhalin AE
Cancer Management and Research 2012, 4:23-29
Published Date: 7 February 2012
Phenotype characterization of embryoid body structures generated by a crystal comet effect tail in an intercellular cancer collision scenario
Diaz JA, Murillo MF
Cancer Management and Research 2012, 4:9-21
Published Date: 23 January 2012
The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab, in the treatment of melanoma
Verschraegen C
Cancer Management and Research 2012, 4:1-8
Published Date: 18 January 2012